Chicago, ILNCT06654752Now EnrollingIRB Ready

Cystic Fibrosis Clinical Trial in Chicago, IL

Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Washington, the Collaborative Health Studies Coordinating Center

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access cystic fibrosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cystic fibrosis treatment provided free

Apply for This Chicago Location

Check if you qualify for this cystic fibrosis clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Cystic Fibrosis Study in Chicago

The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.

Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center

Who Can Participate

Inclusion Criteria

For main cohort and non-HEMT cohort: age 6 to \<19 years
For preschool cohort: age 3 to \<6 years
Documentation of a CF diagnosis as evidenced by one or more clinical features consistent with the CF phenotype and one or more of the following criteria:
sweat chloride ≥ 60 mEq/liter
two disease-causing variants in the cystic fibrosis transmembrane conductive regulator (CFTR) gene
Written informed consent (and assent when applicable) obtained from participant or participant's legal representative and ability of participant to comply with the requirements of the study
Highly Effective Modulator Therapy
For main cohort and preschool cohort: Taking HEMT for at least 3 months at enrollment
For non-HEMT cohort: not eligible for HEMT based on CFTR genotype or eligible but not taking for at least 3 months and no plans to start HEMT in the next year, and also not taking tezacaftor-ivacaftor or lumacaftor-ivacaftor for at least 3 months
For main cohort and non-HEMT cohort: able to perform acceptable and reproducible spirometry
For main cohort and non-HEMT cohort: ppFEV1 ≥ 50% predicted at enrollment based on the Global lung Initiative (GLI) reference equations
Ability to receive text messages and access the internet

Exclusion Criteria

Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the individual or the quality of the data
Receiving an acute course of oral or IV antibiotics at the time of enrollment or within the 14 days prior to enrollment. Individuals may be re-screened ≥21 days after completion of antibiotics if they are at their baseline state of health, per self-report
Treatment with systemic corticosteroids at enrollment or within the 14 days prior to enrollment. Individuals may be re- screened ≥21 days after completion of systemic corticosteroids if they are at their clinical baseline, per self-report
History of solid organ transplant
History of positive culture for Mycobacterium abscessus in the 12 months prior to enrollment
Treatment with antibiotics for any non-tuberculous mycobacteria (NTM) at enrollment
Three or more IV antibiotic-treated PEx in the 12 months prior to enrollment
Treatment with chronic oral antibiotics other than azithromycin at enrollment
Treatment with systemic corticosteroids for allergic bronchopulmonary aspergillosis (ABPA) in the 12 months prior to enrollment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06654752) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cystic Fibrosis Treatment Options in Chicago, IL

If you're searching for cystic fibrosis treatment options in Chicago, IL, this clinical trial (NCT06654752) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cystic fibrosis clinical trials near you to find additional studies recruiting in your area.

More Cystic Fibrosis Trials in Chicago, IL

See all cystic fibrosis clinical trials recruiting in Chicago — not just this study.

Browse Cystic Fibrosis Trials in Chicago →

Browse More Trials by Condition

Cystic Fibrosis TrialsInterstitial Cystitis TrialsFibromyalgia TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL